Evidence map›Paper›PMID 24415155›Full record

ArticleThe Journal of pathology2014

Neuronal inclusions of α-synuclein contribute to the pathogenesis of Krabbe disease.

Benjamin R Smith, Marta B Santos, Michael S Marshall, Ludovico Cantuti-Castelvetri, Aurora Lopez-Rosas, Guannan Li, Richard van Breemen, Kumiko I Claycomb, Jose I Gallea, Maria S Celej and 3 more

Open access · bronzeAbstract read
In one paragraph

Article in The Journal of pathology, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 72 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
72citing papers in PubMed, 1 pooled it
3.8field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

72 citing papers in PubMed, 1 synthesis or guideline pooled it, 107 citations in OpenAlex.

  1. Emerging links between pediatric lysosomal storage diseases and adult parkinsonism.Movement disorders : official journal of the Movement Disorder Society · 2019
    Pooled it
  2. Sphingolipidoses: expanding the spectrum of α-synucleinopathies.Journal of neural transmission (Vienna, Austria : 1996) · 2026
    Review
  3. Very late-onset Krabbe disease with concomitant dementia: case description and a critical review of the literature.Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology · 2026
    Review
  4. Article
  5. Article
  6. Article
  7. Review
  8. Article
  9. Review
  10. Article
  11. Review
  12. Gene therapy for the leukodystrophies: From preclinical animal studies to clinical trials.Neurotherapeutics : the journal of the American Society for Experimental NeuroTherapeutics · 2024
    Review
  13. Article
  14. Review
  15. Review
  16. Article
  17. Review
  18. Neurodegenerative Disorder Risk in Krabbe Disease Carriers.International journal of molecular sciences · 2022
    Article
  19. Review
  20. Article

12 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 3 institutions in 2 countries.

Benjamin R SmithDepartment of Anatomy and Cell Biology, College of Medicine, University of Illinois, University of Illinois Chicago, Chicago, IL, 60612, USA.
Marta B Santos
Michael S Marshall
Ludovico Cantuti-Castelvetri
Aurora Lopez-Rosas
Guannan Li
Richard van Breemen
Kumiko I Claycomb
Jose I Gallea
Maria S Celej
Stephen J Crocker
Maria I Givogri
Ernesto R Bongarzone
University of Illinois Chicago · USResearch Centre in Biological Chemistry of Córdoba · ARUConn Health · US

Funding

Combined Neuroprotection and Metabolic Correction to Treat LeukodystrophiesR01NS065808 · NINDS · UNIVERSITY OF ILLINOIS AT CHICAGO · PI BONGARZONE, ERNESTO ROQUE · 2009 to 2018
$3.0M
NINDS NIH HHS R01 NS065808PHS HHS RNS065808A
6 · The paper itself

Abstract

Demyelination is a major contributor to the general decay of neural functions in children with Krabbe disease. However, recent reports have indicated a significant involvement of neurons and axons in the neuropathology of the disease. In this study, we have investigated the nature of cellular inclusions in the Krabbe brain. Brain samples from the twitcher mouse model for Krabbe disease and from patients affected with the infantile and late-onset forms of the disease were examined for the presence of neuronal inclusions. Our experiments demonstrated the presence of cytoplasmic aggregates of thioflavin-S-reactive material in both human and murine mutant brains. Most of these inclusions were associated with neurons. A few inclusions were detected to be associated with microglia and none were associated with astrocytes or oligodendrocytes. Thioflavin-S-reactive inclusions increased in abundance, paralleling the development of neurological symptoms, and distributed throughout the twitcher brain in areas of major involvement in cognition and motor functions. Electron microscopy confirmed the presence of aggregates of stereotypic β-sheet folded proteinaceous material. Immunochemical analyses identified the presence of aggregated forms of α-synuclein and ubiquitin, proteins involved in the formation of Lewy bodies in Parkinson's disease and other neurodegenerative conditions. In vitro assays demonstrated that psychosine, the neurotoxic sphingolipid accumulated in Krabbe disease, accelerated the fibrillization of α-synuclein. This study demonstrates the occurrence of neuronal deposits of fibrillized proteins including α-synuclein, identifying Krabbe disease as a new α-synucleinopathy.

Indexed as

alpha-SynucleinAnimalsBenzothiazolesBrainCase-Control StudiesCognitionDisease Models, AnimalFluorescent DyesHumansLeukodystrophy, Globoid CellLewy BodiesMiceMotor ActivityMutationNeuronsPsychosinealpha-SynucleinBenzothiazolesFluorescent DyesPsychosineSNCA protein, humanSnca protein, mouseThiazolesthioflavin Taxonal degenerationdying-back pathologyKrabbe diseaseLewy bodiesmyelinpsychosinesynucleinopathiesubiquitinα-synuclein

Identifiers

PMID24415155
PMCPMC3977150
OpenAlexW1547904215

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.